SITC Cancer Immunotherapy CONNECT


Abstract Titles for the 32nd Annual Meeting Now Available

Titles of the newest cancer immunotherapy research set to be unveiled at the SITC 2017 Annual Meeting have now been published! Browse abstract titles then register to join SITC in National Harbor this November.

Browse Abstract Titles

Register Today for Upcoming ACI Programs in Boston & Washington, D.C.

Join SITC for upcoming Advances in Cancer Immunotherapy™ (ACI) programs: Oct. 5 in Boston, MA and Oct. 7 in Washington, D.C. Learn clinical applications of immunotherapy for disease states with FDA-approved treatments and much more!

Register Today for an ACI


29 Young Investigators Leading 2018 SITC Sparkathon Cohort

The SITC Sparkathon, a long-awaited new program enlisting young investigators to identify and solve hurdles facing the field of cancer immunotherapy, has launched! Learn more about the program and the 29 early career scientists who comprise the 2018 Cohort of the SITC Sparkathon.

Meet the 2018 Cohort


Begin your free online education today at SITC Cancer Immunotherapy connectED

SITC connectED is the new adaptive learning portal connecting users to online educational activities about cancer immunotherapy with opportunities for continuing education credits. Start with Introduction to Immunology lead by Christian Capitini, MD (University of Wisconsin).

Explore SITC connectED


The Authoritative Cancer Immunotherapy Reference

SITC members who purchase Cancer Immunotherapy Principles and Practice receive a 20 percent discount and free shipping with a promo code.*

member-ribbon-v4.png*Available only when ordering from Demos Medical Publishing. Cannot be combined with any other offers.

Learn More


Join the Community– Create a Free SITC Cancer Immunotherapy CONNECT Account

Learn and share information in the SITC Cancer Immunotherapy CONNECT Open Forum! Create a free SITC CONNECT account in a few minutes, upload a profile photo and then join the conversation.


Clinical Advances in Cancer Immunotherapy Online Portal

In partnership with Medscape Oncology, SITC offers a robust online learning portal designed to provide clinical oncologists with free, CME-/CE-certified education in the immunotherapy field.

Learn More


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • The Department of Immunology, Genetics and Pathology (IGP) at Uppsala University in Sweden is involved in an ongoing effort to collect cancer patient data in an initiative entitled U-CAN.  By June of this year, the biobank has grown to approximately ...

  • It is the recent modest single agent activity of programmed death-ligand 1 and programmed death receptor-1 antibodies for those with breast cancer that is generating hope for use of immunotherapy in breast cancer. To ponder in the meantime, in preparation ...

  • FYI for those in the Tampa, FL area. Emerging Opportunities--Enhancing Awareness of Clinical Trials The 2017 Breast Immune-Oncology Conference is being held Sat., Oct. 7th at Moffitt Cancer Center. There will be a free companion Patient Advocacy Program ...

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


Publications & Resources

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More